Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Accounts Receivable

ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Accounts Receivable of -$348.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-12

  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$1.27M, a 182.74% decline year-over-year.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$684.00K.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.61M, a 50.28% increase year-over-year.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$1.45M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2025 was $236.00K.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2024 was -$1.97M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2023 was -$11.70M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2022 was -$3.26M, a 3978.57% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2026-06-30-$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
-$1.96M
derived: sum of 2 quarters · filed 2026-08-12
-$348.00K
10-Q · filed 2026-08-12
-$1.80M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$684.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
$927.00K
10-Q · filed 2026-05-13
-$524.00K
derived: sum of 3 quarters · filed 2026-05-13
$1.02M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$1.61M
10-Q · filed 2026-02-11
$160.00K
derived: sum of 2 quarters · filed 2026-02-11
$1.70M
derived: sum of 3 quarters · filed 2026-08-12
$775.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-09-30-$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$90.00K
derived: sum of 2 quarters · filed 2026-08-12
-$836.00K
derived: sum of 3 quarters · filed 2026-08-12
$236.00K
10-K · filed 2025-11-19
2025-06-30$1.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
$615.00K
derived: sum of 2 quarters · filed 2026-08-12
$1.69M
10-Q · filed 2026-08-12
$157.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$926.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
$146.00K
10-Q · filed 2026-05-13
-$1.38M
derived: sum of 3 quarters · filed 2026-05-13
-$964.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$1.07M
10-Q · filed 2026-02-11
-$458.00K
derived: sum of 2 quarters · filed 2026-02-11
-$38.00K
derived: sum of 3 quarters · filed 2026-02-11
-$455.00K
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30-$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
-$1.11M
derived: sum of 2 quarters · filed 2025-11-19
-$1.53M
derived: sum of 3 quarters · filed 2025-11-19
-$1.97M
10-K · filed 2025-11-19
2024-06-30$420.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13
$3.00K
derived: sum of 2 quarters · filed 2025-08-13
-$438.00K
10-Q · filed 2025-08-13
-$10.72M
derived: sum of 4 quarters · filed 2025-11-19
2024-03-31-$417.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14
-$858.00K
10-Q · filed 2025-05-14
-$11.14M
derived: sum of 3 quarters · filed 2025-11-19
-$10.04M
derived: sum of 4 quarters · filed 2025-11-19
2023-12-31-$441.00K
10-Q · filed 2025-02-12
-$10.72M
derived: sum of 2 quarters · filed 2025-11-19
-$9.62M
derived: sum of 3 quarters · filed 2025-11-19
-$14.41M
derived: sum of 4 quarters · filed 2025-11-19
2023-09-30-$10.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
-$9.18M
derived: sum of 2 quarters · filed 2025-11-19
-$13.97M
derived: sum of 3 quarters · filed 2025-11-19
-$11.70M
10-K · filed 2025-11-19
2023-06-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07
-$3.69M
derived: sum of 2 quarters · filed 2024-08-07
-$1.43M
10-Q · filed 2024-08-07
-$587.00K
derived: sum of 4 quarters · filed 2024-11-27
2023-03-31-$4.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08
-$2.52M
10-Q · filed 2024-05-08
-$1.68M
derived: sum of 3 quarters · filed 2024-11-27
-$921.00K
derived: sum of 4 quarters · filed 2024-11-27
2022-12-31$2.27M
10-Q · filed 2024-02-08
$3.11M
derived: sum of 2 quarters · filed 2024-11-27
$3.87M
derived: sum of 3 quarters · filed 2024-11-27
-$5.06M
derived: sum of 4 quarters · filed 2024-11-27
2022-09-30$839.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27
$1.60M
derived: sum of 2 quarters · filed 2024-11-27
-$7.33M
derived: sum of 3 quarters · filed 2024-11-27
-$3.26M
10-K · filed 2024-11-27
2022-06-30$763.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08
-$8.17M
derived: sum of 2 quarters · filed 2023-08-08
-$4.10M
10-Q · filed 2023-08-08
-$2.15M
derived: sum of 4 quarters · filed 2023-11-22
2022-03-31-$8.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09
-$4.86M
10-Q · filed 2023-05-09
-$2.91M
derived: sum of 3 quarters · filed 2023-11-22
-$1.42M
derived: sum of 4 quarters · filed 2023-11-22
2021-12-31$4.07M
10-Q · filed 2023-02-08
$6.02M
derived: sum of 2 quarters · filed 2023-11-22
$7.52M
derived: sum of 3 quarters · filed 2023-11-22
-$4.09M
derived: sum of 4 quarters · filed 2023-11-22
2021-09-30$1.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22
$3.44M
derived: sum of 2 quarters · filed 2023-11-22
-$8.17M
derived: sum of 3 quarters · filed 2023-11-22
$84.00K
10-K · filed 2023-11-22
2021-06-30$1.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08
-$10.12M
derived: sum of 2 quarters · filed 2022-08-08
-$1.87M
10-Q · filed 2022-08-08
$2.97M
derived: sum of 4 quarters · filed 2022-11-23
2021-03-31-$11.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09
-$3.36M
10-Q · filed 2022-05-09
$1.48M
derived: sum of 3 quarters · filed 2022-11-23
-$7.49M
derived: sum of 4 quarters · filed 2022-11-23
2020-12-31$8.25M
10-Q · filed 2022-02-10
$13.09M
derived: sum of 2 quarters · filed 2022-11-23
$4.12M
derived: sum of 3 quarters · filed 2022-11-23
-$20.83M
derived: sum of 4 quarters · filed 2022-11-23
2020-09-30$4.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23
-$4.13M
derived: sum of 2 quarters · filed 2022-11-23
-$29.08M
derived: sum of 3 quarters · filed 2022-11-23
-$27.82M
10-K · filed 2022-11-23
2020-06-30-$8.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09
-$33.92M
derived: sum of 2 quarters · filed 2021-08-09
-$32.66M
10-Q · filed 2021-08-09
-$25.71M
derived: sum of 4 quarters · filed 2021-11-24
2020-03-31-$24.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10
-$23.69M
10-Q · filed 2021-05-10
-$16.75M
derived: sum of 3 quarters · filed 2021-11-24
-$12.01M
derived: sum of 4 quarters · filed 2021-11-24
2019-12-31$1.26M
10-Q · filed 2021-02-09
$8.20M
derived: sum of 2 quarters · filed 2021-11-24
$12.94M
derived: sum of 3 quarters · filed 2021-11-24
-$17.32M
derived: sum of 4 quarters · filed 2021-11-24
2019-09-30$6.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
$11.68M
derived: sum of 2 quarters · filed 2021-11-24
-$18.57M
derived: sum of 3 quarters · filed 2021-11-24
-$15.89M
10-K · filed 2021-11-24
2019-06-30$4.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10
-$25.52M
derived: sum of 2 quarters · filed 2020-08-10
-$22.84M
10-Q · filed 2020-08-10
-$12.89M
derived: sum of 4 quarters · filed 2020-11-25
2019-03-31-$30.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11
-$27.57M
10-Q · filed 2020-05-11
-$17.63M
derived: sum of 3 quarters · filed 2020-11-25
-$4.42M
derived: sum of 4 quarters · filed 2020-11-25
2018-12-31$2.68M
10-Q · filed 2020-02-10
$12.62M
derived: sum of 2 quarters · filed 2020-11-25
$25.84M
derived: sum of 3 quarters · filed 2020-11-25
$46.78M
derived: sum of 4 quarters · filed 2020-11-25
2018-09-30$9.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25
$23.16M
derived: sum of 2 quarters · filed 2020-11-25
$44.10M
derived: sum of 3 quarters · filed 2020-11-25
$56.59M
10-K · filed 2020-11-25
2018-06-30$13.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09
$34.15M
derived: sum of 2 quarters · filed 2019-08-09
$46.65M
10-Q · filed 2019-08-09
$49.75M
derived: sum of 4 quarters · filed 2019-11-27
2018-03-31$20.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10
$33.44M
10-Q · filed 2019-05-10
$36.54M
derived: sum of 3 quarters · filed 2019-11-27
$35.09M
derived: sum of 4 quarters · filed 2019-11-27
2017-12-31$12.49M
10-Q · filed 2019-02-08
$15.60M
derived: sum of 2 quarters · filed 2019-11-27
$14.15M
derived: sum of 3 quarters · filed 2019-11-27
$12.69M
derived: sum of 4 quarters · filed 2019-11-27
2017-09-30$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27
$1.66M
derived: sum of 2 quarters · filed 2019-11-27
$197.00K
derived: sum of 3 quarters · filed 2019-11-27
-$2.23M
10-K · filed 2019-11-27
2017-06-30-$1.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09
-$2.91M
derived: sum of 2 quarters · filed 2018-08-09
-$5.33M
10-Q · filed 2018-08-09
-$6.47M
derived: sum of 4 quarters · filed 2018-11-29
2017-03-31-$1.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10
-$3.88M
10-Q · filed 2018-05-10
-$5.02M
derived: sum of 3 quarters · filed 2018-11-29
-$4.04M
derived: sum of 4 quarters · filed 2018-11-29
2016-12-31-$2.42M
10-Q · filed 2018-02-09
-$3.56M
derived: sum of 2 quarters · filed 2018-11-29
-$2.59M
derived: sum of 3 quarters · filed 2018-11-29
-$7.45M
derived: sum of 4 quarters · filed 2018-11-29
2016-09-30-$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29
-$163.00K
derived: sum of 2 quarters · filed 2018-11-29
-$5.03M
derived: sum of 3 quarters · filed 2018-11-29
-$2.45M
10-K · filed 2018-11-29
2016-06-30$974.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09
-$3.89M
derived: sum of 2 quarters · filed 2017-08-09
-$1.31M
10-Q · filed 2017-08-09
$2.25M
derived: sum of 4 quarters · filed 2017-12-11
2016-03-31-$4.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10
-$2.29M
10-Q · filed 2017-05-10
$1.28M
derived: sum of 3 quarters · filed 2017-12-11
$5.92M
derived: sum of 4 quarters · filed 2017-12-11
2015-12-31$2.58M
10-Q · filed 2017-02-09
$6.14M
derived: sum of 2 quarters · filed 2017-12-11
$10.79M
derived: sum of 3 quarters · filed 2017-12-11
-$58.76M
derived: sum of 4 quarters · filed 2017-12-11
2015-09-30$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11
$8.21M
derived: sum of 2 quarters · filed 2017-12-11
-$61.34M
derived: sum of 3 quarters · filed 2017-12-11
$13.56M
10-K · filed 2017-12-11
2015-06-30$4.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
-$64.90M
derived: sum of 2 quarters · filed 2016-08-09
$10.00M
10-Q · filed 2016-08-09
$11.32M
derived: sum of 4 quarters · filed 2016-12-09
2015-03-31-$69.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10
$5.36M
10-Q · filed 2016-05-10
$6.68M
derived: sum of 3 quarters · filed 2016-12-09
$6.08M
derived: sum of 4 quarters · filed 2016-12-09
2014-12-31$74.90M
10-Q · filed 2016-02-09
$76.23M
derived: sum of 2 quarters · filed 2016-12-09
$75.63M
derived: sum of 3 quarters · filed 2016-12-09
$76.35M
derived: sum of 4 quarters · filed 2016-12-09
2014-09-30$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09
$726.00K
derived: sum of 2 quarters · filed 2016-12-09
$1.45M
derived: sum of 3 quarters · filed 2016-12-09
$916.00K
10-K · filed 2016-12-09
2014-06-30-$599.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10
$120.00K
derived: sum of 2 quarters · filed 2015-08-10
-$409.00K
10-Q · filed 2015-08-10
-$477.00K
derived: sum of 4 quarters · filed 2015-12-11
2014-03-31$719.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08
$190.00K
10-Q · filed 2015-05-08
$122.00K
derived: sum of 3 quarters · filed 2015-12-11
$329.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-12-31-$529.00K
10-Q · filed 2015-02-06
-$597.00K
derived: sum of 2 quarters · filed 2015-12-11
-$390.00K
derived: sum of 3 quarters · filed 2015-12-11
-$14.05M
derived: sum of 4 quarters · filed 2015-12-11
2013-09-30-$68.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11
$139.00K
derived: sum of 2 quarters · filed 2015-12-11
-$13.53M
derived: sum of 3 quarters · filed 2015-12-11
-$241.00K
10-K · filed 2015-12-11
2013-06-30$207.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12
-$13.46M
derived: sum of 2 quarters · filed 2014-08-12
-$173.00K
10-Q · filed 2014-08-12
-$1.10M
derived: sum of 4 quarters · filed 2014-12-11
2013-03-31-$13.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12
-$380.00K
10-Q · filed 2014-05-12
-$1.30M
derived: sum of 3 quarters · filed 2014-12-11
$584.00K
derived: sum of 4 quarters · filed 2014-12-11
2012-12-31$13.28M
10-Q · filed 2014-02-13
$12.36M
derived: sum of 2 quarters · filed 2014-12-11
$14.25M
derived: sum of 3 quarters · filed 2014-12-11
2012-09-30-$924.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11
$964.00K
derived: sum of 2 quarters · filed 2014-12-11
$788.00K
10-K · filed 2014-12-11
2012-06-30$1.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12
$1.71M
10-Q · filed 2013-08-12
2012-03-31-$176.00K
10-Q · filed 2013-05-15
2011-09-30$251.00K
10-K · filed 2013-12-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63